RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-15 5:12 pm Sale | 2022-08-15 | 13G | KalVista Pharmaceuticals, Inc. KALV | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -1,930,322 (Position Closed) | Filing |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | RA CAPITAL MANAGEMENT L.P. | 1,930,322 7.900% | 530,833 (+37.93%) | Filing |
| 2021-05-27 4:44 pm Purchase | 2021-05-24 | 13G | KalVista Pharmaceuticals, Inc. KALV | RA CAPITAL MANAGEMENT L.P. | 1,399,489 5.700% | 613,219 (+77.99%) | Filing |